Methodology of a standardized worldwide epidemiological study: the International Diabetes Management Practices Study (IDMPS)

P ASCHNER; SH BAIK; J CHAN; S FERREIRA; JJ GAGLIARDINO; ET AL.

San Diego, California

Congreso; 65th Scientific Session of the American Diabetes Association; 2005

American Diabetes Association

 Despite the results of large pivotal triáis demonstrating the benefit of tight control of diabetes mellitus (DM) and the recommendations of international guidelines, a large number of DM patients are not well controlled, and do not reach the generally accepted HbAlc target value below 7%. While several national or regional epidemiological studies have been already conducted in DM patients and there have also been international collaborations from various countries (with the limitation of non-standardized data collection), no single international epidemiological study has assessed the current prac­tices in DM management and its evolution over time.The aim of the International Diabetes Management Practices Study (IDMPS) is to collect data worldwide in a standardized manner, and to use this data base to assess 1)real world current practices in the management of DM patients and changes over time, and 2) variations in diabetes management practices across countries. This survey involves in each participating country, a representative panel of physicians who are entitled to prescrie insulin. It includes adult patients with type 1 or type 2 DM. It is a two-part study: a standardized 2-week cross-sectional survey during which each physician will recruit type 1 and type 2 DM patients consulting during this period, and a 9-month longitudinal survey to follow-up the insulin-treated patients. Each part of the study will be repeated once a year over 5 years. It is anticipated that the study will indícate how representative patients from different countries are being managed, including changes in tose achieving HbAlc targets over time and changing pattems of diabetes medication usage.